Supernus Pharmaceuticals SG&A Expense (Quarterly) Analysis

Supernus Pharmaceuticals Inc (SUPN)

30.83 +0.56 (+1.85%) USD | NASDAQ | May 03, 16:00

30.84 +0.01 (+0.03%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2009. Upgrade now.

Date	Value
December 31, 2023	81.28M
September 30, 2023	82.70M
June 30, 2023	86.78M
March 31, 2023	85.60M
December 31, 2022	73.97M
September 30, 2022	112.31M
June 30, 2022	100.48M
March 31, 2022	90.46M
December 31, 2021	101.74M
September 30, 2021	72.03M
June 30, 2021	69.54M
March 31, 2021	61.46M
December 31, 2020	56.50M
September 30, 2020	54.46M
June 30, 2020	48.10M
March 31, 2020	41.61M
December 31, 2019	34.46M
September 30, 2019	39.34M
June 30, 2019	39.78M
March 31, 2019	40.97M
December 31, 2018	36.86M
September 30, 2018	40.89M
June 30, 2018	40.10M
March 31, 2018	36.85M
December 31, 2017	33.76M

Date	Value
September 30, 2017	40.82M
June 30, 2017	35.08M
March 31, 2017	28.24M
December 31, 2016	29.05M
September 30, 2016	25.68M
June 30, 2016	26.12M
March 31, 2016	25.16M
December 31, 2015	23.57M
September 30, 2015	22.90M
June 30, 2015	23.19M
March 31, 2015	19.40M
December 31, 2014	18.06M
September 30, 2014	17.44M
June 30, 2014	19.58M
March 31, 2014	17.53M
December 31, 2013	15.22M
September 30, 2013	14.62M
June 30, 2013	12.21M
March 31, 2013	13.53M
December 31, 2012	8.682M
September 30, 2012	4.075M
June 30, 2012	4.645M
March 31, 2012	2.728M
December 31, 2011	2.785M
September 30, 2011	1.501M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

34.46M

Minimum

Dec 2019

112.31M

Maximum

Sep 2022

70.14M

Average

72.03M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks